<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Belgian Atherosclerosis Society / Belgian Lipid Club</title>
	<atom:link href="https://www.basoc.be/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.basoc.be</link>
	<description>National representative of the European Atherosclerosis Society</description>
	<lastBuildDate>Thu, 14 Nov 2024 09:37:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.5.15</generator>

<image>
	<url>https://www.basoc.be/wp-content/uploads/2021/03/cropped-Logo-32x32.png</url>
	<title>Belgian Atherosclerosis Society / Belgian Lipid Club</title>
	<link>https://www.basoc.be</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Focus on lipoprotein (a) – Lp(a)</title>
		<link>https://www.basoc.be/focus-lipoprotein-lpa/</link>
					<comments>https://www.basoc.be/focus-lipoprotein-lpa/#respond</comments>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Thu, 14 Nov 2024 09:26:52 +0000</pubDate>
				<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=496</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-embed-youtube wp-block-embed is-type-video is-provider-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe title="[FR] Lpa consensus local webinar Belgium" width="1220" height="686" src="https://www.youtube.com/embed/Oc8z9je2GiM?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div><figcaption>Vidéo du webinar en français</figcaption></figure>



<p></p>



<figure class="wp-block-embed-youtube wp-block-embed is-type-video is-provider-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe title="[NL] Lpa consensus local webinar Belgium" width="1220" height="686" src="https://www.youtube.com/embed/QXtE6gqktuc?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div><figcaption>Vidéo du webinar en néerlandais</figcaption></figure>
]]></content:encoded>
					
					<wfw:commentRss>https://www.basoc.be/focus-lipoprotein-lpa/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Congress &#8211; Heart &#038; Lipids</title>
		<link>https://www.basoc.be/congress-heart-lipids/</link>
					<comments>https://www.basoc.be/congress-heart-lipids/#respond</comments>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Tue, 04 Oct 2022 13:51:00 +0000</pubDate>
				<category><![CDATA[Non classé]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=472</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[
<div class="wp-block-columns">
<div class="wp-block-column">
<figure class="wp-block-image size-large is-style-default"><a href="https://mailchi.mp/liguecardioliga.be/congrs-accrdit-coeur-lipides/"><img loading="lazy" width="463" height="1024" src="https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-463x1024.png" alt="" class="wp-image-483" srcset="https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-463x1024.png 463w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-136x300.png 136w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-695x1536.png 695w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-66x146.png 66w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-23x50.png 23w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr-34x75.png 34w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-fr.png 715w" sizes="(max-width: 463px) 100vw, 463px" /></a></figure>
</div>



<div class="wp-block-column">
<figure class="wp-block-image size-large is-style-default"><a href="https://mailchi.mp/liguecardioliga.be/congres-met-accreditering/"><img loading="lazy" width="538" height="1024" src="https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-538x1024.png" alt="" class="wp-image-484" srcset="https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-538x1024.png 538w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-158x300.png 158w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-77x146.png 77w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-26x50.png 26w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl-39x75.png 39w, https://www.basoc.be/wp-content/uploads/2022/10/invitation-newsletter-nl.png 715w" sizes="(max-width: 538px) 100vw, 538px" /></a></figure>
</div>
</div>
]]></content:encoded>
					
					<wfw:commentRss>https://www.basoc.be/congress-heart-lipids/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Guidelines of lipid management in cardiovascular prevention</title>
		<link>https://www.basoc.be/tele-medecine/</link>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Wed, 07 Oct 2020 14:29:34 +0000</pubDate>
				<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=122</guid>

					<description><![CDATA[With each new European guidelines (every 3 to 6 years), we propose here the summary of these guidelines in the national languages which answers the questions<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[
<p>With each new European guidelines (every 3 to 6 years), we propose here the summary of these guidelines in the national languages which answers the questions most often asked in terms of cardiovascular prevention as well as a table with a simple alogorithm and tables to calculate the risk in primary prevention</p>



<p>French and dutch summary of the guidelines</p>



<figure class="wp-block-image size-large"><img loading="lazy" width="1024" height="576" src="https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-1024x576.jpg" alt="" class="wp-image-372" srcset="https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-1024x576.jpg 1024w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-300x169.jpg 300w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-768x432.jpg 768w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-260x146.jpg 260w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-50x28.jpg 50w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-133x75.jpg 133w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations-1200x675.jpg 1200w, https://www.basoc.be/wp-content/uploads/2021/03/Algorithme-des-recommandations.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<figure class="wp-block-image size-large"><img loading="lazy" width="1024" height="576" src="https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-1024x576.jpg" alt="" class="wp-image-373" srcset="https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-1024x576.jpg 1024w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-300x169.jpg 300w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-768x432.jpg 768w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-260x146.jpg 260w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-50x28.jpg 50w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-133x75.jpg 133w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen-1200x675.jpg 1200w, https://www.basoc.be/wp-content/uploads/2021/03/Algoritme-voor-aanbevelingen.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p class="btn-link"><a rel="noreferrer noopener" href="https://www.basoc.be/download/2020-descamps-os-louvain-medical-guidelines-tap/?ind=1612968696048&amp;filename=2020%20Descamps%20OS.%20Louvain%20Medical%20Guidelines%20avec%20associ%C3%A9s%20FR%20TAP.pdf&amp;wpdmdl=334&amp;refresh=612f238a2ec5e1630479242" data-type="URL" data-id="https://www.basoc.be/download/2020-descamps-os-louvain-medical-guidelines-tap/?ind=1612968696048&amp;filename=2020%20Descamps%20OS.%20Louvain%20Medical%20Guidelines%20avec%20associ%C3%A9s%20FR%20TAP.pdf&amp;wpdmdl=334&amp;refresh=612f238a2ec5e1630479242" target="_blank">Recommandation, Résumé en français</a>   </p>



<p class="btn-link"><a rel="noreferrer noopener" href="https://www.basoc.be?wpdmdl=334&amp;ind=1612968698005" data-type="URL" data-id="https://www.basoc.be?wpdmdl=334&amp;ind=1612968698005" target="_blank">Aanbeveling, samenvatting in het Nederlands</a></p>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cardiovascular risk assessment for cardiovascular prevention</title>
		<link>https://www.basoc.be/outils-a-disposition/</link>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Wed, 07 Oct 2020 14:28:22 +0000</pubDate>
				<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=120</guid>

					<description><![CDATA[Deciding on the best cardiovascular prevention strategy for a patient begins by establishing in which cardiovascular risk category the patient is. Once the category has been<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[
<p>Deciding on the best cardiovascular prevention strategy for a patient begins by establishing in which cardiovascular risk category the patient is. Once the category has been established, the therapeutic targets (LDL-C and non-HDL-C) as well as the means to achieve them can be determined</p>



<p class="btn-link"><a href="https://www.basoc.be?wpdmdl=377&amp;ind=1615557727406" data-type="URL" data-id="https://www.basoc.be?wpdmdl=377&amp;ind=1615557727406" target="_blank" rel="noreferrer noopener">Algorithme des recommandations</a></p>



<p class="btn-link"><a href="https://www.basoc.be?wpdmdl=377&amp;ind=1615557726377" data-type="URL" data-id="https://www.basoc.be?wpdmdl=377&amp;ind=1615557726377" target="_blank" rel="noreferrer noopener">Algorithme voor aanbevelingen</a></p>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>SCORE of risk assessment in primary prevention</title>
		<link>https://www.basoc.be/score-of-risk-assessment-in-primary-prevention/</link>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Wed, 07 Oct 2020 14:19:47 +0000</pubDate>
				<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=118</guid>

					<description><![CDATA[The cardiovascular risk is calculated on the basis of the Belgian score chart that you will find here Evaluation des risques SCORE en prévention primaire SCORE<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[
<p>The cardiovascular risk is calculated on the basis of the Belgian score chart that you will find here</p>



<p class="btn-link"><a href="https://www.basoc.be?wpdmdl=316&amp;ind=1604669788972" data-type="URL" data-id="https://www.basoc.be?wpdmdl=316&amp;ind=1604669788972" target="_blank" rel="noreferrer noopener">Evaluation des risques SCORE en prévention primaire</a></p>



<p class="btn-link"><a href="https://www.basoc.be?wpdmdl=316&amp;ind=1604669788974" data-type="URL" data-id="https://www.basoc.be?wpdmdl=316&amp;ind=1604669788974" target="_blank" rel="noreferrer noopener">SCORE risicobeoordeling bij primaire preventive</a></p>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Criteria for the diagnosis of familial hypercholesterolemia in adults and children</title>
		<link>https://www.basoc.be/bilan-lipidique/</link>
		
		<dc:creator><![CDATA[Olivier Descamps]]></dc:creator>
		<pubDate>Wed, 07 Oct 2020 14:16:51 +0000</pubDate>
				<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://www.basoc.be/?p=116</guid>

					<description><![CDATA[Here you will find tools to assess the likelihood of familial hypercholesterolemia (FH) in an adult in whom you discover very high cholesterol, in the brother<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[
<p>Here you will find tools to assess the likelihood of familial hypercholesterolemia (FH) in an adult in whom you discover very high cholesterol, in the brother or sister or close relative of a person with whom you have already had the diagnosis of HF, as well as in a child</p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=309&amp;ind=1604667705146" data-type="URL" data-id="https://www.basoc.be?wpdmdl=309&amp;ind=1604667705146" target="_blank" rel="noreferrer noopener">Critères du Dutch Lipid Clinic Network (DLCN) <br>pour le diagnostic de l&#8217;hypercholestérolémie familiale hétérozygote chez l&#8217;adulte</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=309&amp;ind=1604667705147" data-type="URL" data-id="https://www.basoc.be?wpdmdl=309&amp;ind=1604667705147" target="_blank" rel="noreferrer noopener">Criteria van het Dutch Lipid Clinic Network (DLCN) <br>voor de diagnose van heterozygote familiaire hypercholesterolemie bij volwassenen</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=366&amp;ind=1615555833159" data-type="URL" data-id="https://www.basoc.be?wpdmdl=366&amp;ind=1615555833159" target="_blank" rel="noreferrer noopener">Critères pour le diagnostic de l&#8217;hypercholestérolémie familiale hétérozygote chez un enfant</a></p>



<p class="has-text-align-center btn-link"><a rel="noreferrer noopener" href="https://www.basoc.be?wpdmdl=366&amp;ind=1615555855134" data-type="URL" data-id="https://www.basoc.be?wpdmdl=366&amp;ind=1615555855134" target="_blank">Criteria voor de diagnose van heterozygote familiaire hypercholesterolemie bij een kind</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=369&amp;ind=1615556337688" data-type="URL" data-id="https://www.basoc.be?wpdmdl=369&amp;ind=1615556337688" target="_blank" rel="noreferrer noopener">Critères pour le diagnostic de l&#8217;hypercholestérolémie familiale hétérozygote chez un adulte parent d&#8217;un patient chez qui vous avez diagnostiqué une HF</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=369&amp;ind=1651065701993" target="_blank" rel="noreferrer noopener">Criteria voor de diagnose van heterozygote familiaire hypercholesterolemie Bij een volwassen familielid van een patiënt bij wie u de diagnose HF heeft gesteld</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=431&amp;ind=1633002969087" target="_blank" rel="noreferrer noopener">Lettre que vous pouvez remettre à votre patients chez qui a été diagnostiqué une HF, afin d&#8217;alerter les membres de sa famille ainsi que leur médecin traitant</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=431&amp;ind=1633002973065">Brief die u kunt geven aan uw patiënten die zijn gediagnosticeerd met HF, om deze familieleden en hun behandelend arts te waarschuwen</a></p>



<p class="has-text-align-center btn-link"><a href="https://www.basoc.be?wpdmdl=462&amp;ind=1650872788571">Diagnostiquer l’hypercholestérolémie familiale chez un patient et les membres de sa famille (français seulement)&nbsp;</a></p>



<p></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
